destiny-breast04: practice-changing results for her2-low breast cancer
Published 2 years ago • 1.2K plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:08
destiny-breast04: a ground-breaking trial in her2-low breast cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
1:09
the exciting new field of her2-low breast cancer
-
2:05
latest news in her2-low breast cancer
-
1:16
her2-low expression in breast cancer
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
1:24
novel treatment options for her2-low breast cancer
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
4:18
asco 2022: destiny-breast04, paloma-2, reecur
-
11:12
her2-low breast cancer: destiny or good science?
-
1:33
questions remaining in the field of her2-low breast cancer
-
2:21
adcs for the treatment of her2-low breast cancer
-
0:31
remaining questions regarding her2-low breast cancer
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
1:20:02
her2-low expression in breast cancer: opportunities for expanding treatment benefit to more patients
-
6:51
adcs for her2 and her2-low breast cancer
-
0:45
the evolution of her2-low breast cancer from primary to recurrence
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
7:13
overview of the management of her2-low breast cancer patients
-
0:56
remaining questions on the management of her2-low breast cancer
-
11:30
evaluating landmark clinical data for her2-low breast cancer
-
5:02
reflections on the destiny-breast04 trial | patricia lorusso